Levetiracetam
Product Images NDC 15955-327

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 15955-327). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Orit Laboratories Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Levetiracetam 01)

Chemical structure diagram of levetiracetam, showing its molecular configuration with a pyrrolidone ring and acetamide group.*

FDA Label Image

Figure 1 (Levetiracetam 02)

Bar graph showing the percentage of patients across three groups: Placebo (7.4%), Levetiracetam 1000 mg/day (37.1%), and Levetiracetam 3000 mg/day (39.6%). The x-axis indicates treatment groups with sample sizes, and the y-axis shows the percentage of patients. Asterisks mark values for Levetiracetam groups.*

FDA Label Image

Figure 2 (Levetiracetam 03)

Bar chart depicting the percentage of patients in three groups: Placebo (6.3%), Levetiracetam 1000 mg/day (20.8%), and Levetiracetam 2000 mg/day (35.2%). The chart compares patient response rates across different dosages of Levetiracetam and a placebo group.*

FDA Label Image

Figure 3 (Levetiracetam 04)

A bar chart comparing the percentage of patients for two groups: Placebo (104 patients) and Levetiracetam 3000 mg/day (180 patients). The chart shows approximately 14.4% of patients in the Placebo group and 39.4% in the Levetiracetam group.*

FDA Label Image

Figure 4 (Levetiracetam 05)

Bar graph comparing the percentage of patients between two groups: Placebo (N=97) and Levetiracetam (N=101). The y-axis represents the percentage of patients, ranging from 0% to 45%. The Levetiracetam group shows a higher percentage (44.6%) compared to the Placebo group (19.6%).*

FDA Label Image

Figure 6 (Levetiracetam 06)

A bar chart comparing the percentage of patients between Placebo and Levetiracetam groups. The chart shows approximately 45.2% for Placebo (N=84) and 72.2% for Levetiracetam (N=79), with the y-axis labeled as % of Patients and values ranging from 0% to 100%.*

FDA Label Image

Principal Display Panel (473 mL Bottle Label)

Levetiracetam Oral Solution, USP 100 mg/mL by Orit Laboratories LLC. The label displays dosage form as oral solution with a 16 fl oz (473 mL) volume. It includes storage instructions, pharmacist dispensing guidance, and a warning to keep out of reach of children. Manufacturer is Silarx Pharmaceuticals, Inc., with distribution by Orit Laboratories LLC. The label shows the NDC number 15955-327-16 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.